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Abstract
The use of low polarity aromatic solvents (benzene or toluene) and/or the removal of inorganic
salts results in dramatically improved yields of fluorinated arenes from diaryliodonium salts. This
methodology is shown to “scale down” to the conditions used typically for radiotracer synthesis.
The inability to functionalize electron-rich arenes with fluoride ion sources narrows the
scope and increases the expense of practical 18F-labeled imaging agents for positron
emission tomography.1 Two fluoride-based approaches to fluoroarenes have been heavily
investigated of late: 1) transition-metal-catalyzed fluorination,2-6 and 2) elimination of aryl
fluorides from diaryliodonium salts.7,8 Stang and coworkers have stressed the similarities of
iodonium ion and late transition metal ion chemistries,9 thus we thought that the use of low
polarity, non-coordinating media, which often suppresses ionic (disproportionation, ligand
exchange, electron transfer) side reactions of transition metal complexes,10 might be a
strategy to improve diaryliodonium fluoride chemistry. Here we show that the use of
benzene solvent and/or removal of “inert” electrolyte is associated with substantially
improved yields of fluorinated aromatic compounds from the decomposition of
diaryliodonium fluorides. These results have significant ramifications for the preparation of
fluorinated radiotracers.
Previously we reported the preparation of phenyliodonium difluoride from anhydrous
tetrabutylammonium fluoride11 (TBAF) and phenyliodonium diacetate.12 In the course of
this work we noted that excess fluoride ion led to the eventual reduction of PhIF2 to PhI and
bifluoride ion by an unknown mechanism. This reaction was largely suppressed in nonpolar
solvents such as benzene. Similarly, if bis(4-methoxyphenyl)iodonium hexafluorophosphate
1 is treated with excess anhydrous TBAF or anhydrous tetramethylammonion fluoride13
(TMAF) in acetonitrile at ambient temperature, 4-iodoanisole is formed without the
generation of any fluorinated arenes. If substoichiometric amounts of fluoride are present the
decomposition reaction is largely suppressed at room temperature, but upon heating of the
sdimagno1@unl.edu .
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acetonitrile solution 1 undergoes thermal decomposition to form 4-fluoroanisole (4FA) in
poor yield (17%) along with 4-iodoanisole and anisole. Given that the redox chemistry of
PhIF2 was suppressed in benzene, we investigated the thermal decomposition of
diaryliodonium fluoride salts in nonpolar media as well. Initial experiments (Figure 1)
indicated that this approach might be fruitful.
To test the generality of this approach, diaryliodonium hexafluorophosphates 2-7 (Figure 2)
were prepared by two established methods: 3 and 5-7 were prepared by TsOH catalyzed
electrophilic aromatic substitution of anisole by ArI(OAc)2, 14,15 and compounds 2 and 4
were prepared from the corresponding tributylstannanes and p-OMePhI(OH)(OTs) (Figure
3).16,17 The iodonium salts were isolated by precipitation from aqueous solutions using
NaPF6. (Full experimental procedures are provided in the Supporting Information.)
Several procedures for diaryliodonium fluoride decomposition were investigated. In the
first, compounds 1-7 were treated with 1 equivalent of anhydrous TMAF in CD3CN and
heated (140 °C, 15 min) in sealed NMR tubes. Yields of fluorinated arenes were determined
by 1H NMR spectroscopy and confirmed by GC-MS analysis. In the second method, ion
exchange with TMAF was performed in acetonitrile, the solvent was evaporated, and the
remainder was suspended in d6-benzene and heated (140 °C, 15 min) in sealed NMR tubes.
A comparison of the results from these two procedures is given in Table 1. In all cases, the
yields of fluorinated arenes were superior for the reactions conducted in benzene. In
acetonitrile, the formation of HF2− and BF4− (from the borosilicate NMR tube) was
observed, whereas no inorganic fluoride byproducts were seen when benzene was the
reaction solvent. Inspection of the results shows that the 4-methoxyphenyl group strongly
directs the fluoride nucleophile to the electron-poor aromatic ring, as is generally observed
when diaryliodonium salts are fluorinated with cyclotron-derived 18F-fluoride ion.1
In addition to reducing the solvent polarity, the use of benzene as the reaction solvent
effectively removes the inorganic spectator ions (tetramethylammonium and
hexafluorophosphate) from solution. While these salts are not expected to participate
directly in the thermal decomposition reaction, their presence might facilitate ligand
exchange reactions and increase the I-F dissociation rate and dissociation constants. To
probe whether the observed improvement in fluorination yield was a function of solvent
polarity or extraneous salt, the thermal decomposition of the diaryliodonium fluorides was
also conducted under “salt free” conditions in both solvents.
Salt removal was performed by a simple solvent exchange process; compounds 2-7 were
dissolved in CH3CN, treated with TMAF and the solvent was evaporated. The remaining
salts were dissolved in benzene and passed through a 0.20 μm PTFE syringe filter (Scheme
1). Upon evaporation of the benzene, clean samples of the diaryliodonium salts were
obtained. 1H and 19F NMR spectra of the isolated diaryliodonium fluorides showed no
residual TMAPF6 in the samples of diaryliodonium fluorides prepared using this solvent
exchange method.
The results of thermal decomposition reactions (140 °C, 15 min) of the “salt free”
diaryliodonium fluorides are summarized in Table 2. For reactions conducted in benzene,
salt-free conditions were associated with a modest enhancement in the yields of fluorinated
arenes. In contrast, the yields of reactions conducted in CD3CN improved dramatically after
the salt was removed; in some instances the yields obtained for the thermal decomposition
of salt-free diaryliodonium fluorides in acetonitrile approached those seen for reactions
conducted in benzene. These results suggest that fluoride ion dissociation may be
responsible for some degradation of the arene fluorination efficiency observed in polar
aprotic solvents.
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Deuterated benzene is a particularly convenient and relatively inexpensive solvent for
conducting these iodonium salt decomposition experiments, but its carcinogenicity makes
benzene unattractive for practical preparations. Thus, we also investigated the thermal
decomposition reactions of compounds 1-7 in d8-toluene under salt free conditions. The
yields and selectivities for formation of fluorinated arenes from 1-7 (Table S1, Supporting
Information) were essentially identical to those obtained for reactions conducted in C6D6,
indicating that a wide range of nonpolar aromatic solvents might be readily used for this
process.
Compounds 8 and 9, suitably protected precursors of previously investigated
radiotracers 18F-6-fluorodopamine18 and 18F-2-fluoroestradiol,19 respectively, were
decomposed to the corresponding fluorinated arenes in excellent (80% for 8) and fair (42%
for 9) yields in benzene. The reduced fluorination yield for the latter compound is
accompanied by a concomitant increase in the amount of 4-fluoroanisole produced,
consistent with the similar “directing group” abilities of the 2-methoxy and 4-methoxy
substituted arenes. (Recently, our laboratory reported a potential solution to this directing
group problem.20) Successful fluorination of these arenes indicates that the methodology is
sufficiently broad to tolerate suitably protected alcohol and amine functionality.
To more closely mimic the conditions of radiotracer synthesis, we examined the thermal
decomposition reactions of 1 at three concentrations (1 mM, 5 μM, and 5 nM); radiotracer
synthesis is typically conducted in the nM-μM 18F-fluoride concentration range. Since our
studies were conducted exclusively with 19F-fluoride, we needed an appropriate analytical
tool to test the impact of dilution upon the yield of fluorinated arenes. For product analysis
we used a GC-TOF-MS; this technique was sufficiently sensitive to detect and quantify
reproducibly 500 femtograms of injected 4-fluoroanisole. To minimize fluoride losses due to
adsorption on glass surfaces during the dilution process, 1 was first treated with TBAF and
the bis(4-methoxyphenyl)iodonium fluoride 1(F) was isolated.
Under standard thermal decomposition conditions (140 °C, 15 min, 0.5 mL of benzene) the
yield of 4-fluoroanisole declined sharply with the concentration of 1(F): 1 mM – 90%, 5 μM
– 30%, 5 nM – 0%. In contrast, thermal decomposition of a mixture of 5 ng 1(F) and excess
(1 mg) bis(4-methoxyphenyl)iodonium trifluoroacetate under standard conditions gave
excellent and reproducible yields of 4-fluoroanisole (80 ± 10% by GC-TOF-MS). (Control
experiments in which bis(4-methoxyphenyl)iodonium trifluoroacetate was heated in benzene
without added 1(F) produced no detectable fluoroanisole.)
Taken together, the results reported here show that the perhaps counterintuitive choice of
nonpolar media for the pyrolysis of highly polar diaryliodonium fluorides has an important
and practical impact on the success of arene fluorination, and that these new conditions give
excellent yields of fluorinated arenes. Even when the total concentration of fluoride ion is
vanishingly small, as it is when 18F-fluorinated radiotracers are synthesized, the presence of
excess diaryliodonium substrate leads to excellent conversion to the fluorinated arene. In
addition to suppressing deleterious side reactions, an important role of the nonpolar solvent
is to precipitate inorganic salts that may catalyze ligand exchange, electron transfer, and
disproportionation reactions. These new conditions have their genesis in the hypothesis that
I(III) behaves like a transition metal ion, and long-standing observations of fluoride's
propensity to promote the disproportionation of low-valent transition metal ions. Studies to
demonstrate the direct application of these new reaction conditions in 18F-radiotracer
synthesis are currently underway.
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Figure 1.
Solvent effect upon the decomposition of bis(4-methoxyphenyl)iodonium fluoride.
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Figure 2.
Direct decomposition of diaryliodonium fluorides in C6D6 and CD3CN at 140 °C.
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Figure 3.
Preparation of diaryliodonium salts 2-7. a) NaBO3, AcOH, 40 °C, 8 h; b) TsOH·H2O,
anisole, CH3CN; c) H2O, NaPF6; d) Pd2(dba)3, P(t-Bu)3, benzene, Sn2Bu6, 100 °C; e) p-
(OMe)PhI(OTs)(OH), CH3CN.
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Scheme 1.
Salt removal by solvent exchange process.
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Figure 4.
Syntheses of compounds 8 and 9. a) Br2, AcOH, rt, KOH; b) diisopropylethylamine,
phthaloyl dichloride, CH3CN, rt; c) Pd2(dba)3, t-Bu3P, benzene, Sn2Bu6, 100 °C; d) p-
OMePhI(OTs)(OH), CH3CN; e. H2O, NaPF6; f) NBS, CH3CN/CCl4 (3:7) ; g) n-BuLi,
Bu3SnCl, THF, −78 °C to rt.
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Figure 5.
a) Total ion chromatogram of the decomposition reaction mixture of 1(F) in acetonitrile; b)
Selected ion chromatogram of the same reaction mixture (mass range = 126.03-126.04).
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Table 1
Yields of fluorinated arenes obtained from direct decomposition of salts 1-7.
Cmpd.
C6D6
(ArF + 4FA)a
CD3CN
(ArF + 4FA)
1 76 17
2 (59 + 19) (2 + 1)
3 (59 + 25) (2 + 1)
4 (76 + 14) (2 + 1)
5 (41 + 10) (3 + 1)
6 (86 + 0) (33 + 0)
7 (93 + 5) 0
a
The numbers inside the parentheses indicate the percentage yields of the desired fluorinated arenes followed by the amount of 4-fluoroanisole
(4FA) produced during the reaction. All solutions were heated at 140 °C for 15 minutes in sealed NMR tubes.
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Table 2
Yields of fluorinated arenes obtained from decomposition of salts 1-7 after removal of TMAPF6.
“Salt Free” Conditions
Cmpd.
C6D6
(ArF + 4FA)a
CD3CN
(ArF + 4FA)
1 86 43
2 (77 + 14) (30 + 8)
3 (49 + 23) (40 + 20)
4 (78 + 12) (49 + 32)
5 (57 + 20) (40 + 15)
6 (85 + 10) (68 + 0)
7 (89 + 0) (78 + 0)
a
The numbers inside the parentheses indicate the percentage yields of the desired fluorinated arene followed by the amount of 4-fluoroanisole
(4FA) produced during the reaction. All solutions were heated at 140 °C for 15 minutes in sealed NMR tubes.
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Materials: All materials were obtained from commercial sources and used as received unless otherwise 
noted. Tetramethylammonium fluoride (TMAF) and diphenyliodonium nitrate were dried at 60-80 °C in 
a drying pistol (charged with P2O5) under dynamic vacuum for one week. Hexabutyldistannane and 
chlorotributylstannane were distilled in vacuo into flame-dried storage tubes and stored under dry 
nitrogen. Acetonitrile and acetonitrile-d3 were heated at reflux over P2O5, distilled into flame-dried 
storage tubes, transferred to the glove box, and were stored there over CaH2. Benzene and benzene-d6 
were heated at reflux over CaH2 overnight and distilled directly into flame-dried storage tubes under dry 
nitrogen. Toluene-d8 was distilled over CaH2 into flame-dried storage tubes and stored over molecular 
sieves. All glassware, syringes, and NMR tubes were oven dried (140 °C) for more than 24 h before they 
were transferred into the glove box for use.  TBAF was synthesized according to our previously reported 
method.1 All NMR experiments reported here were performed using a Bruker Avance 400 MHz NMR 
spectrometer in the NMR laboratory at the University of Nebraska-Lincoln. 
 
Procedures:  
 
Bis(acetyloxy)-(4-methoxyphenyl)-λ3 –iodane; (1-(diacetoxyiodo)-4-methoxybenzene, 1a) 
I OAcAcO
OCH3  
4-Iodoanisole (2.34 g, 10 mmol) was dissolved in 90 mL of glacial acetic acid and the stirred solution 
was warmed to 40 °C. Sodium perborate tetrahydrate (13.6 g, 110 mmol) was added in portions over the 
course of one hour. After the addition was complete, the temperature of the reaction mixture was 
maintained at 40 °C for 8 h before it was allowed to cool to room temperature. Half of the acetic acid (~ 
45 mL) was removed by distillation at reduced pressure. The remaining solution was treated with 100 
mL of deionized water and the aqueous layer was extracted (3 × 40 mL) with dichloromethane. The 
combined organic fractions were dried over sodium sulfate, and the solvent was removed by rotary 
evaporation to give 2.25 g (64%) of 1-(diacetoxyiodo)-4-methoxybenzene, 1a. This compound was 
dried in vacuo and used without further purification. 1H NMR (CD3CN, 400 MHz, 25 °C): δ 8.055 (d, J 
= 9.1 Hz, 2H, H2/H6), 7.053 (d, J = 9.1 Hz, 2H, H3/H5), 3.861 (s, 3H, OMe), 1.905 (s, 6H, 
(OCOCH3)2); 13C NMR (CD3CN, 100 MHz, 25 °C) δ 177.73 (CO), 163.73 (C4), 138.75 (C2/C6), 
118.00, (C3/C5), 111.97 (C1), 56.85 (OMe), 20.76 ((OCOCH3)2); HRMS: (HRFAB) calcd. for 
C14H13NO4I [M – 2OAc+3-NBA]+ 385.9889 found 385.9885. (lit. 2,3 13C NMR (CDCl3, 50 MHz, 20 °C) 
δ 162.0 (C4), 137.0 (C2/C6), 116.5 (C3/C5), 111.4 (C1).); 13C NMR (CDCl3, 75 MHz, 25 °C) δ 176.31 
(CO), 111.64 (C1), 20.36 ((OCOCH3)2).) 
Bis(acetyloxy)-(2-methoxyphenyl)-λ3 –iodane; (1-(diacetoxyiodo)-2-methoxybenzene, 3a) 
I OAcAcO
O
CH3
 
S3 
2-Iodoanisole (2.34 g, 10 mmol) was dissolved in 90 mL of glacial acetic acid and the stirred solution 
was warmed to 40 °C. Sodium perborate tetrahydrate (13.6 g, 110 mmol) was added in portions over the 
course of one hour. After the addition was complete, the temperature of the reaction mixture was 
maintained at 40 °C for 8 h before it was allowed to cool to room temperature. Half of the acetic acid (~ 
45 mL) was removed by distillation at reduced pressure. The remaining solution was treated with 100 
mL of deionized water and the aqueous layer was extracted (3 × 40 mL) with dichloromethane. The 
combined organic fractions were dried over sodium sulfate, and the solvent was removed by rotary 
evaporation to give 2.29 g (65%) of 1-(diacetoxyiodo)-2-methoxybenzene. This compound was dried in 
vacuo and used without further purification. 1H NMR (CD3CN, 400 MHz, 25 °C): δ 8.175 (d, J = 8.0 
Hz, 1H, H6), 7.690 (dd, J1 = 7.6, J2= 8.2 Hz 1H, H5), 7.313 (d, J =8.2 Hz, 1H, H3), 7.085 (dd, J1 =8.0, 
J2=7.6 Hz, 1H, H4), 3.958 (s, 3H, OMe), 1.884(s, 6H, (OCOCH3)2); 13C NMR (CD3CN, 100 MHz, 25 
°C) δ 178.00 (CO), 157.72(C2), 139.09 (C6), 136.34 (C4), 124.17 (C3), 113.91 (C1), 113.87 (C5), 58.20 
(OMe), 20.71((OCOCH3)2); HRMS (HRFAB): calcd. for C14H13NO4I [M – 2OAc+3-NBA]+ 385.9889 
found 385.9874. (lit.4 1H NMR δ (270 MHz, CDCl3) 8.10 (1H, d, H6 J = 8 Hz), 7.56 (1H, t, H5 J = 8 
Hz), 7.13 (1H, d, H3, J = 8 Hz), 7.00 (1H, t, H4 J = 8 Hz), 3.95 (3H, s, OCH3), 1.93 (6H, s, 
(OCOCH3)2); 13C NMR (68 MHz; CDCl3) δ 176.7 (CO), 156.3 (C3), 137.8, 134.6, 122.9, 113.4 (C1), 
112.1, 57.0 (OMe), 20.5 ((OCOCH3)2).) 
Bis(acetyloxy)-(3-(trifluoromethy)phenyl)-λ3 –iodane; (1-(diacetoxyiodo)-3-
(trifluoromethyl)benzene, 6a) 
I OAcAcO
CF3  
1-(Diacetoxyiodo)-3-(trifluoromethyl)benzene (3.12 g, 80%) was prepared from 3-iodobenzotrifluoride 
(2.72 g, 10 mmol) using the identical procedure used to prepare 1a. 1H NMR (CD3CN, 400 MHz, 25 
°C): δ 8.492 (s, H1, C2), 8.397 (d, J = 8.3 Hz, 1H, C6), (d, J = 7.9 Hz, 1H, C4), (dd, J1 = 8.3 Hz, J2 = 7.9 
Hz, 1H, C5), 1.939 (s, 6H, (OCOCH3)2); 13C NMR (CD3CN, 100 MHz, 25 °C) δ 178.03 (CO), 140.25 
(C6), 133.45 (q, J = 33.5 Hz, C3), 133.24 (q, J = 3.9 Hz, C2), 133.14 (C5), 130.07 (q, J = 3.7 Hz, C4), 
123.96 (q, J = 273.1 Hz, CF3), 122.02 (C1), 20.73 ((OCOCH3)2); 19F NMR (CD3CN, 376MHz, 25 °C) δ 
-63.255 (1JC-F= 273.1 Hz, 2JC-F= 33.5 Hz); HRMS (HRFAB): calcd. for C14H10NO3IF3 [M – 2OAc+3-
NBA]+ 423.9657 found 423.9645. (lit.5: 1H NMR (300 MHz, CDCl3) δ 2.03 (s, 6 H, (OCOCH3)2), 7.65 
(t, J = 7.9 Hz, 1 H, ArH), 7.85 (d, J = 7.9 Hz, 1H, ArH), 8.28 (d, J = 7.9 Hz, 1 H, ArH), 8.33 (s, 1 H, 
ArH); 13C NMR (75 MHz, CDCl3) δ 176.5, 138.1, 132.9 (q, JCF = 33.4 Hz, CCF3), 131.7 (q, JCF = 3.7 
Hz, CCCF3), 131.2, 128.4 (q, JCF = 3.7 Hz, CCCF3), 122.7 (q, JCF = 270.8 Hz, CF3), 120.9, 20.2.) 
 
Bis(acetyloxy)-(3-cyanophenyl)-λ3 –iodane; (3-(diacetoxyiodo)benzonitrile, 7a) 
I OAcAcO
CN  
S4 
3-(Diacetoxyiodo)benzonitrile (2.43 g, 70%) was prepared from 3-iodobenzonitrile (2.29 g, 10 mmol) 
using the identical procedure used to prepare 1a. 1H NMR (CD3CN, 400 MHz, 25 °C): δ 8.515 (s, 1H, 
H2), 8.406 (d, J = 8.1 Hz, 1H, H6), 7.866 (d, J = 8.1 Hz, 1H, H4), 7.711 (t, J = 8.1 Hz, 1H, H5), 1.954 (s, 
6H, (OCOCH3)2); 13C NMR (CD3CN, 100 MHz, 25 °C) δ 178.25 (CO), 140.65 (C6), 139.69 (C2), 
136.88 (C5), 132.95 (C4), 121.84 (C3), 115.82 (CN), 109.99 (C1); HRMS (HRFAB): calcd. for 
C14H10N2O3I [M – 2OAc+3-NBA]+ 380.9736 found 380.9722. (lit.6: 1H NMR (CDCl3, 200 MHz) δ 
7.61-8.39(4H, m, ArH), 2.02(6H, s, MeCO2).) 
Bis(4-methoxyphenyl)iodonium hexafluorophosphate (1d) 
I OMeMeO
PF
F F
F
F
F
 
In a glove box under nitrogen, 1-(diacetoxyiodo)-4-methoxybenzene (1a) (352 mg, 1 mmol) was 
weighed into a glass vial and 1.5 mL of dry acetonitrile was added. A solution containing p-
toluenesulfonic acid monohydrate (190 mg, 1 mmol) dissolved in 1.5 mL of dry acetonitrile was added 
by syringe. Upon completion of the addition, 4-iodoanisole (neat, 0.11 mL, 1 mmol) was added and the 
vial was sealed and taken out of the glove box; the mixture was allowed to stir at room temperature for 2 
h. Water (10 mL) was added and the mixture was transferred to a separatory funnel and extracted (3 × 5 
mL) with hexanes. The reserved aqueous layer was treated with 502 mg (3 mmol) of NaPF6. The white 
precipitate was filtered, dried in vacuo, and recrystallized in a mixture of diethyl ether/dichloromethane 
to give 391 mg of bis(4-methoxyphenyl)iodonium hexafluorophosphate (80.5%). 1H NMR (CD3CN, 400 
MHz, 25 °C): δ 7.973 (d, J = 9.1 Hz, 4H, H2/H2’/H6/H6’), 7.046 (d, J = 9.1 Hz, 4H, H3/H3’/H5/H5’), 
3.833 (s, 6H, OMe); 13C NMR (CD3CN, 100 MHz, 25 °C) δ 164.61 (C4/C4’), 138.55 (C2/C2’/C6/C6’), 
119.42 (C3/C3’/C5/C5’), 103.36 (C1/C1’), 57.06 (OMe); 19F NMR (CD3CN, 376 MHz, 25 °C) δ -
72.833 (d, 1JP-F = 707.3 Hz, PF6-); HRMS (HRFAB): calcd. for C14H14O2I [M – PF6]+ 341.0038 found 
341.0036. 
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Bis(4-methoxyphenyl)-trifluoroacetoxy- λ3-iodane; (bis(4-methoxyphenyl)iodonium 
trifluoroacetate, 1e) 
I OMeMeO
O
O
CF3
 
In a nitrogen flushed Schlenk tube equipped with a magnetic stir bar and a rubber septum seal, 1-
(diacetoxyiodo)-4-methoxybenzene (1a) (1.41 g, 4 mmol) was dissolved in 30 mL of dry 
dichloromethane and the solution was cooled to -30 °C.  Trifluoroacetic acid (0.61 mL, 8 mmol) was 
added and the solution was allowed to warm slowly to room temperature and stirred for 30 min. 
Subsequently, the solution was cooled to -30 °C and anisole (0.44mL, 4 mmol) was added dropwise by 
syringe. When the addition was complete, the mixture was allowed to warm to room temperature and 
stirred for an additional 1 h. The solvent was removed by rotary evaporation and the residual solid was 
recrystallized from diethyl ether/dichloromethane to give 1.53 g (71%) of bis(4-
methoxyphenyl)iodonium trifluoroacetate. 1H NMR (CD3CN, 400 MHz, 25 °C): δ 7.951 (d, J = 9.1 Hz, 
4H, H2/H2’/H6/H6’), 6.981 (d, J = 9.1 Hz, 4H, H3/H3’/H5/H5’), 3.805 (s, 6H, OMe); 13C NMR 
(CD3CN, 100 MHz, 25 °C) δ 163.84 (C4/C4’), 138.14 (C2/C2’/C6/C6’), 118.69 (C3/C3’/C5/C5’), 
106.64 (C1/C1’), 56.86 (OMe); 19F NMR (CD3CN, 376 MHz, 25 °C) δ -75.436 (CF3-, 1JC-F = 297.3 Hz, 
1JC-F = 33.3 Hz). 
Bis(4-methoxyphenyl)-fluoro-λ3-iodane; (bis(4-methoxyphenyl)iodonium fluoride, 1(F) 
IMeO
F
OMe
 
In a glove box under nitrogen, a mixture of 454 mg (1 mmol) bis(4-methoxyphenyl)iodonium 
trifluoroacetate (1e) and 262 mg (1 mmol) anhydrous tetrabutylammonium fluoride (TBAF) was treated 
with 1 mL of dry tetrahydrofuran (THF). The solution was allowed to stand for 1 h, the white precipitate 
was collected and washed (3 × 0.5 mL) with THF. Calculated yield: 288.7 mg (80.2%). Iodonium salts 
were shielded from the light during all operations. 1H NMR (saturated solution in CD3CN, 400 MHz, 25 
°C): δ 7.739 (d, J = 8.9 Hz, 4H, H2/H2’/H6/H6’), 6.853 (d, J = 8.9 Hz, 4H, H3/H3’/H5/H5’), 3.769 (s, 
6H, OMe); 13C NMR (CD3CN, 100 MHz, 25 °C) δ 162.43 (C4/C4’), 136.98 (C2/C2’/C6/C6’), 117.52 
(C3/C3’/C5/C5’), 113.20 (C1/C1’), 56.55 (OMe); 19F NMR (CD3CN, 376 MHz, 25 °C) δ -17.91 (broad 
s, I-F). 
3,4-Dimethoxyphenyltributyltin (2c) 
SnBu3MeO
MeO
 
In a glove box under nitrogen, 4-bromoveratrole (1.085 g, 5 mmol) and Pd(PPh3)4 (289 mg , 0.25 mmol) 
were dissolved in 15 mL of dry toluene. The solution was transferred into a storage tube equipped with 
PTFE chemcap seal, and hexabutylditin (3.19 g, 5 mmol) was added. The tube was sealed, taken out of 
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the glove box, and heated at 120 °C for 48 h. The reaction mixture was allowed to cool to room 
temperature and diluted with hexane (15 mL) before saturated aqueous KF solution (15 mL) was added. 
The mixture was stirred for 30 min, filtered through celite, and the organic layer was separated. The 
solvent was removed in vacuo to give the crude product as a yellow oil. The crude product was purified 
by column chromatography (Rf = 0.4, hexane/dichloromethane 98/2, basic alumina) to give 1.69 g 
(79.1%) of 3,4-dimethoxyphenyltributyltin. 1H NMR (C6D6, 400 MHz, 25 °C): δ 7.097 (d, J = 7.7 Hz, 
1H, H6), 7.074 (s, 1H, H2), 6.744 (d, J = 7.7 Hz, 1H, H5), 3.557 (s, 3H, 3-OMe), 3.443 (s, 3H, 4-OMe), 
1.632 (m, 6H, βCH2), 1.384 (m, 6H, γCH2), 1.117 (m, 6H, αCH2), 0.912 (t, J = 7.6 Hz, 9H, CH3), 
(coupling to 117Sn and 119Sn observed, J ranged from 10.7 – 41.3 Hz); 13C NMR (C6D6, 100 MHz, 25 
°C) δ 151.21 (C4), 150.66 (C6), 132.35 (C1), 130.13 (C3), 120.75 (C5), 113.12 (C2), 56.21 (3-OMe), 
55.75 (4-OMe), 29.87 (γC), 28.16 (βC), 14.31 (δC), 10.32 (αC), (coupling to 117Sn and 119Sn observed, J 
ranged from 1.0 – 320.8 Hz); HRMS (HRFAB): calcd. for C20H37O2Sn [M + H]+ 429.1815 found 
429.1799. (lit.7: 1H NMR (CDCl3): δ 6.7 - 7.3 (m, 3H, Ar-H), 3.89 (s, 3H, OMe), 3.86 (s, 3H, OMe), 
1.1-1.8 (m, 18H, 9 × CH2), 0.89 (s, 9H, 3 × CH3); b.p. 166-172 °C/0.4mmHg.) 
(3,4-Dimethoxyphenyl)-(4’-methoxyphenyl)iodonium hexafluorophosphate (2d) 
IMeO
PF
F F
F
F
F
OMe
OMe
 
In a glove box under nitrogen, 1-(diacetoxyiodo)-4-methoxybenzene (352 mg, 1 mmol) was dissolved in 
1.5 mL of dry acetonitrile and a solution of p-toluenesulfonic acid monohydrate (190 mg, 1 mmol) in 1.5 
mL of dry acetonitrile was added. 3,4-Dimethoxyphenyl)tributyltin, 2c (427 mg, 1 mmol) was added and 
the mixture was allowed to react at room temperature for 2 h. Water (10 mL) was added and the mixture 
was extracted (3 × 5 mL) with hexanes. The aqueous layer was treated with NaPF6 (502 mg, 3 mmol) 
and the white precipitate was filtered, dried in vacuo, and recrystallized with 
diethylether/dichloromethane to give 370 mg (71.7%)  of(3,4-dimethoxyphenyl)(4’-
methoxyphenyl)iodonium hexafluorophosphate. 1H NMR (CD3CN, 400 MHz, 25 °C): δ 7.986 (d, J = 9.1 
Hz, 2H, H2’/H6’), 7.647 (dd, J1 =8.9 Hz, J2 = 2.2 Hz, 1H, H6), 7.558 (d, J = 2.2 Hz, 1H, H2), 7.049 (d, J 
= 9.1 Hz, 2H, H3’/H5’), 7.022 (d, J = 8.9 Hz, 1H, H5), 3.845 (s, 3H, 3-OMe), 3.843 (s, 3H, 4’-OMe), 
3.834 (s, 3H, 4-OMe); 13C NMR (CD3CN, 100 MHz, 25 °C) δ 164.58 (C4’), 154.62 (C4), 152.50 (C3), 
138.49 (C2’/C6’), 130.65 (C6), 119.38 (C2), 119.13 (C3’/C5’), 115.52 (C5), 103.37 (C1), 102.64 (C1’), 
57.49 (3-OMe), 57.14 (4’-OMe), 57.05 (4-OMe); 19F NMR (CD3CN, 376 MHz, 25 °C) δ -72.786 (d, 1JP-
F = 705.8 Hz, PF6-); HRMS (HRFAB): calcd. for C15H16O3I [M – PF6]+ 371.0144 found 371.0156. 
 (2-Methoxyphenyl)-(4’-methoxyphenyl)iodonium hexafluorophosphate (3d) 
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IMeO
P
F
F F
F
F
F
MeO  
In a glove box under nitrogen, 1-(diacetoxyiodo)-2-methoxybenzene, 3a, (352 mg, 1 mmol) was 
weighed into a glass vial and 1.5 mL of dry acetonitrile was added. A solution containing p-
toluenesulfonic acid monohydrate (190 mg, 1 mmol) dissolved in 1.5 mL of dry acetonitrile was added 
by syringe. Upon completion of the addition, 4-iodoanisole (neat, 0.11 mL, 1 mmol) was added. The vial 
was sealed and taken out of the glove box; the mixture was allowed to stir at room temperature for 2 h. 
Water (10 mL) was added and the mixture was transferred to a separatory funnel and extracted (3 × 5 
mL) with hexanes. The reserved aqueous layer was treated with 502 mg (3 mmol) of NaPF6. The white 
precipitate was filtered, dried in vacuo, and recrystallized in a mixture of diethyl ether/dichloromethane 
to give 405 mg (83.3%) of (2-methoxyphenyl)-(4’-methoxyphenyl)iodonium hexafluorophosphate. 1H 
NMR (CD3CN, 400 MHz, 25 °C): δ 7.988 (d, J = 9.2 Hz, 2H, H2’/H6’), 7.878 (d, J =8.4 Hz, 1H, H6), 
7.659 (td, J1 = 8.4 Hz, J2 = 1.3 Hz,1H, H4), 7.232 (dd, J1 = 8.4 Hz, J2 = 1.3 Hz, 1H, H5), 7.063 (td, J1 =  
8.4 Hz, J2 = 1.3 Hz, 1H, H3), 7.051 (d, J = 9.2, 2H, H3’/H5’), 3.970 (s, 3H, 2-OMe), 3.841 (s, 3H, 4’-
OMe); 13C NMR (CD3CN, 100 MHz, 25 °C) δ 164.73 (C4’), 157.90 (C2), 139.52 (C2’/C6’), 137.08 
(C4), 136.79 (C6), 125.36 (C3), 119.44 (C3’/C5’), 114.70 (C5), 104.69 (C1), 100.92 (C1’), 58.40 (2-
OMe), 57.06 (4’-OMe); 19F NMR (CD3CN, 376 MHz, 25 °C) δ -72.675 (d, 1JP-F = 706.2 Hz, PF6-); 
HRMS (HRFAB): calcd. for C14H14O2I [M – PF6]+ 341.0038 found 341.0035. 
1-Bromo-4,5-dimethoxy-2-methylbenzene (4b) 
CH3
BrMeO
MeO
 
To a stirred solution of 3,4-dimethoxytoluene (3.6 mL, 25 mmol) in 125 mL of acetonitrile was added 
N-bromosuccinimide (4.9 g, 27.5 mmol). The mixture was stirred at room temperature for 2 h, the 
solvent was removed by rotary evaporation, and 100 mL of CCl4 was added. The solid was succinimide 
was removed by filtration, the solvent was removed by rotary evaporation, and the crude product was 
recrystallized from hexane to afford 5.2 g (90%) of 1-bromo-4,5-dimethoxy-2-methylbenzene. 1H NMR 
(CD3CN, 400 MHz, 25 °C): δ 7.022 (s, 1H, H6), 6.822 (s, 1H, H3), 3.752 (s, 3H, OMe), 3.744 (s, 3H, 
OMe), 2.269(s, 3H, Me); 13C NMR (CD3CN, 100 MHz, 25 °C) δ 149.91 (C5), 149.33 (C4), 130.73 
(C2), 116.73 (C6), 115.35 (C3), 115.12 (C1); HRMS (HRCI): calcd. for C9H12O2Br [M + H]+ 231.0021, 
233.0000 found 231.0011, 233.0013. (lit.8: 1H NMR (CDCl3, 300 MHz): δ 7.000 (s, 1H, Ar-H), 6.731 (s, 
1H, Ar-H), 3.874 (s, 3H, -OMe), 3.843 (s, 3H, OMe), 2.327 (s, 3H, -Me).) 
(4,5-Dimethoxy-2-methylphenyl)tributyltin (4c) 
SnBu3MeO
MeO
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In a glove box under nitrogen, 1-bromo-4,5-dimethoxy-2-methylbenzene (4b) (1.155 g, 5 mmol) and 
Pd(PPh3)4 (289 mg ,0.25 mmol) were dissolved in 15 mL of dry toluene. The solution was transferred 
into a storage tube equipped with PTFE chemcap seal and hexabutylditin (3.19 g, 5 mmol) was added. 
The tube was sealed, removed from the glove box, and heated at 120 °C for 48 h. The reaction mixture 
was allowed to cool to room temperature and diluted with hexane (15 mL) before saturated aqueous KF 
solution (15 mL) was added. The mixture was stirred for 30 min, filtered through celite, and the organic 
layer was separated. The solvent was removed to give the crude product as a yellow oil. The crude 
product was purified by column chromatography (Rf = 0.4, hexane/dichloromethane 98/2, basic 
alumina) to give 1.68 g (76.2%) of (4,5-dimethoxy-2-methyl-phenyl)tributyltin. 1H NMR (C6D6, 400 
MHz, 25 °C): δ 7.048 (s, 1H, H6), 6.661 (s, 1H, H3), 3.593 (s, 3H, 3-OMe), 3.458 (s, 3H, 4-OMe), 
2.358 (s, 3H, 2-Me), 1.615 (m, 6H, βCH2), 1.384 (m, 6H, γCH2), 1.143 (m, 6H, αCH2), 0.910 (t, J = 7.6 
Hz, 9H, CH3), (coupling to 117Sn and 119Sn observed, J ranged from 5.4 – 45.6 Hz); 13C NMR (C6D6, 
100 MHz, 25 °C) δ 151.11 (C4), 148.36 (C2), 137.98 (C5), 131.85 (C1), 121.44 (C3), 114.65 (C6), 
56.53 (3-OMe), 55.78 (4-OMe), 30.04 (γC), 28.18 (βC), 25.04 (2-Me), 14.28 (δC), 10.77 (αC), 
(coupling to 117Sn and 119Sn observed, J ranged from 1.0 – 326.2 Hz); HRMS (HRFAB): calcd. for 
C21H39O2Sn [M + H]+ 443.1972 found 443.1982. 
(4,5-Dimethoxy-2-methylphenyl)-(4’-methoxyphenyl)iodonium hexafluorophosphate (4d) 
IMeO
PF
F F
F
F
F
OMe
OMe
 
In a glove box under nitrogen, 1-(diacetoxyiodo)-4-methoxybenzene (352 mg, 1 mmol) was dissolved in 
1.5 mL of dry acetonitrile. A solution containing p-toluenesulfonic acid monohydrate (190 mg, 1 mmol) 
dissolved in 1.5 mL of dry acetonitrile was added by syringe. Upon completion of the addition, (4,5-
dimethoxy-2-methylphenyl)tributyltin (4c) (441 mg, 1 mmol) added. The vial was sealed and taken out 
of the glove box and the mixture was allowed to stir at room temperature for 2 h. Water (10 mL) was 
added and the mixture was transferred to a separatory funnel and extracted (3 × 5 mL) with hexanes. 
The reserved aqueous layer was treated with 502 mg (3 mmol) of NaPF6. The white precipitate was 
filtered, dried in vacuo, and recrystallized in a mixture of diethyl ether/dichloromethane to give 397 mg 
(75%) of (4,5-dimethoxy-2-methylphenyl)(4’-methoxyphenyl)iodonium hexafluorophosphate. 1H NMR 
(CD3CN, 400 MHz, 25 °C): δ 7.939 (d, J = 9.2 Hz, 2H, H2’/H6’), 7.593 (s, 1H, H6), 7.055 (d, J = 9.2 
Hz, 2H, H3’/H5’), 7.026 (s, 1H, H5), 3.835 (s, 6H, 3/4’-OMe), 3.828 (s, 3H, 4-OMe), 2.550 (s, 3H, 2-
Me); 13C NMR (CD3CN, 100 MHz, 25 °C) δ 164.45 (C4’), 154.63 (C4), 150.46 (C5), 138.28 (C2’/C6’), 
136.71 (C2), 120.59 (C6), 119.41 (C3’/C5’), 115.28 (C3), 107.01 (C1), 102.58 (C1’), 57.51 (3-OMe), 
57.14 (4’-OMe), 57.04 (4-OMe); 19F NMR (CD3CN, 376 MHz, 25 °C) δ -72.735 (d, 1JP-F = 706.9 Hz, 
PF6-); HRMS (HRFAB): calcd. for C16H18O3I [M – PF6]+ 3385.0301 found 3385.0313. 
Phenyl-(4-methoxyphenyl)iodonium hexafluorophosphate (5d) 
S9 
IMeO
PF
F F
F
F
F
 
In a glove box under nitrogen, diacetoxyiodobenzene (322 mg, 1 mmol) was weighed into a glass vial 
and 1.5 mL of dry acetonitrile was added. A solution containing p-toluenesulfonic acid monohydrate 
(190 mg, 1 mmol) dissolved in 1.5 mL of dry acetonitrile was added by syringe. Upon completion of the 
addition, 4-iodoanisole (neat, 0.11 mL, 1 mmol) was added and the vial was sealed and taken out of the 
glove box; the mixture was allowed to stir at room temperature for 2 h. Water (10 mL) was added and 
the mixture was transferred to a separatory funnel and extracted (3 × 5 mL) with hexanes. The reserved 
aqueous layer was treated with 502 mg (3 mmol) of NaPF6. The white precipitate was filtered, dried in 
vacuo, and recrystallized in a mixture of diethyl ether/dichloromethane to give 355 mg (77.9%) of 
phenyl-(4-methoxyphenyl)iodonium hexafluorophosphate. 1H NMR (CD3CN, 400 MHz, 25 °C): δ 8.022 
(d, J = 7.6 Hz, 2H, H2/H6), 8.011 (d, J =9.4 Hz, 2H, H2’/H6’), 7.701 (t, J = 7.6 Hz, 1H, H4), 7.734 (t, J 
= 7.6 Hz, 2H, H3/H5), 7.063 (d, J = 9.4 Hz, 2H, H3’/H5’), 3.839 (s, 6H, OMe); 13C NMR (CD3CN, 100 
MHz, 25 °C) δ 164.77 (C4’), 139.04 (C2’/C6’), 136.22 (C2/C6), 134.27 (C4), 133.77 (C3/C5), 119.58 
(C3’/C5’), 115.29 (C1), 102.50 (C1’), 57.09 (OMe); 19F NMR (CD3CN, 376 MHz, 25 °C) δ -72.754 (d, 
1JP-F = 707.7 Hz, PF6-); HRMS (HRFAB): calcd. for C13H12OI [M – PF6]+ 310.9925 found 310.9932. 
 
(3-(Trifluoromethyl)phenyl)-(4’-methoxyphenyl)iodonium hexafluorophosphate (6d) 
IMeO
P
F
F F
F
F
F
CF3  
In a glove box under nitrogen, 1-(diacetoxyiodo)-3-(trifluoromethyl)benzene (6a) (390 mg, 1 mmol) was 
weighed into a glass vial and 1.5 mL of dry acetonitrile was added. A solution containing p-
toluenesulfonic acid monohydrate (190 mg, 1 mmol) dissolved in 1.5 mL of dry acetonitrile was added 
by syringe. Upon completion of the addition, 4-iodoanisole (neat, 0.11 mL, 1 mmol) was added and the 
vial was sealed and taken out of the glove box; the mixture was allowed to stir at room temperature for 2 
h. Water (10 mL) was added and the mixture was transferred to a separatory funnel and extracted (3 × 5 
mL) with hexanes. The reserved aqueous layer was treated with 502 mg (3 mmol) of NaPF6. The white 
precipitate was filtered, dried in vacuo, and recrystallized in a mixture of diethyl ether/dichloromethane 
to give 503 mg (96.1%) of (3-(trifluoromethyl)phenyl)-(4’-methoxyphenyl)iodonium 
hexafluorophosphate. 1H NMR (CD3CN, 400 MHz, 25 °C): δ 8.384 (s, 1H, H2), 8.266 (d, J = 8.1 Hz, 
1H, H6), 8.056 (d, J = 9.2 Hz, 2H, H2’/H6’), 7.996 (d, J = 8.1 Hz, 1H, H4), 7.716 (t, J = 8.1 Hz, 1H, 
H5), 7.083 (d, J = 9.2, 2H, H3’/H5’), 3.847 (s, 3H, 4’-OMe); 13C NMR (CD3CN, 100 MHz, 25 °C) δ 
164.99 (C4’), 139.99 (C6), 139.38 (C2’/C6’), 134.44 (C5), 134.281 (q, J = 33.6 Hz, C3), 133.08 (q, J = 
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3.7 Hz, C2), 133.05 (q, J = 3.7 Hz, C4), 124.11 (q, J = 272.8 Hz, CF3), 119.71 (C3’/C5’), 114.83 (C1), 
102.54 (C1’), 57.13 (4’-OMe); 19F NMR (CD3CN, 376 MHz, 25 °C) δ -63.420 (1JF-C= 272.8 Hz, 2JF-C= 
33.6 Hz, CF3), -72.625 (d, 1JP-F = 707.1 Hz, PF6-); HRMS (HRFAB): calcd. for C14H11OIF3 [M – PF6]+ 
378.9807 found 378.9817. 
 
(3-Cyanophenyl)-(4’-methoxyphenyl)iodonium hexafluorophosphate (7d) 
IMeO
PF
F F
F
F
F
CN  
In a glove box under nitrogen, 3-(diacetoxyiodo)benzonitrile (7a) (347 mg, 1 mmol) was weighed into a 
glass vial and 1.5 mL of dry acetonitrile was added. A solution containing p-toluenesulfonic acid 
monohydrate (190 mg, 1 mmol) dissolved in 1.5 mL of dry acetonitrile was added by syringe. Upon 
completion of the addition, 4-iodoanisole (neat, 0.11 mL, 1 mmol) was added and the vial was sealed 
and taken out of the glove box. The mixture was allowed to stir at room temperature for 2 h. Water (10 
mL) was added and the mixture was transferred to a separatory funnel and extracted (3 × 5 mL) with 
hexanes. The reserved aqueous layer was treated with 502 mg (3 mmol) of NaPF6. The white precipitate 
was filtered, dried in vacuo, and recrystallized in a mixture of diethyl ether/dichloromethane to give 354 
mg (73.7%) of (3-cyanophenyl)-(4’-methoxyphenyl)iodonium hexafluorophosphate. 1H NMR (CD3CN, 
400 MHz, 25 °C): δ 8.389 (t, J = 1.6 Hz, 1H, H2), 8.273 (dd, J1 = 8.2 Hz, J2 = 1.6 Hz, 1H, H6), 8.038 (d, 
J = 9.4 Hz, 2H, H2’/H6’), 8.017 (dd, J1 = 8.2 Hz, J2 = 1.6 Hz, 1H, H4), 7.665 (t, J = 8.2 Hz, 1H, H5), 
7.082 (d, J = 9.4, 2H, H3’/H5’), 3.850 (s, 3H, 4’-OMe); 13C NMR (CD3CN, 100 MHz, 25 °C) δ 165.04 
(C4’), 140.40 (C6), 139.50 (C2), 139.47 (C2’/C6’), 137.79 (C5), 134.13 (C4), 119.75 (C3’/C5’), 117.63 
(C3), 116.75 (CN), 114.53 (C1), 102.56 (C1’), 57.16 (4’-OMe); 19F NMR (CD3CN, 376 MHz, 25 °C) δ 
-72.675 (d, 1JP-F = 707.5 Hz, PF6-); HRMS (HRFAB): calcd. for C14H11NOI [M – PF6]+ 335.9885 found 
335.9876. 
 
2-(2-Bromo-4,5-dimethoxyphenyl)ethanamine (8f) 
Br
NH2
MeO
MeO
 
A solution of bromine (1.1 mL, 22 mmol) in acetic acid (10 mL) was added slowly to a vigorously 
stirred solution of 2-(3,4-dimethoxyphenyl)ethanamine (3.4 mL, 20 mmol) in 50 mL of acetic acid. The 
mixture was stirred for two hours, filtered, and the isolated solid was washed with dichloromethane (3 × 
10 mL) and petroleum ether (3 × 10 mL). The remaining solid was dissolved in water and the pH was 
adjusted to 10 with aqueous KOH solution. The aqueous solution was extracted with dichloromethane (3 
× 10 mL) and the combined organic layers were evaporated to give 4.12g (78%)  of 2-(2-bromo-4,5-
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dimethoxyphenyl)ethananamine. The crude product was dried under dynamic vacuum overnight and 
used without further purification. 1H NMR (CD3CN, 400 MHz, 25 °C): δ 7.00 (s, 1H, H6), 6.73 (s, 1H, 
H3), 3.85 (s, 3H, OMe), 3.84 (s, 3H, OMe), 2.94 (t, J = 7.17 Hz, 2H, CH2), 2.81 (t, J = 7.17 Hz, 2H, 
CH2), 1.24 (s, 2H, NH2); 13C NMR (CD3CN, 100 MHz, 25 °C): δ 148.34 (C5), 148.07 (C4), 131.09 
(C2), 115.66 (C6), 114.33 (C1), 113.43 (C3), 56.15 (OMe), 42.40 (CH2), 39.92 (CH2); HRMS 
(HRFAB): calcd. for C10H14O2NBr [M + H]+ 262.0266, 260.0286 found 262.0262, 260.0276. (lit.9: 1H 
NMR δ 1.38, s, NH2; 2.8-2.9, m, CH2Ar; 2.9-3.0, m, CH2N; 3.85, s, OCH3; 3.86, s, OCH3; 6.74, s, 1H. 
13C NMR δ 39.8, CH2; 42.3, CH2; 56.1, 2× OCH3; 113.4, C3 or C6; 114.3, CBr; 115.6, C6 or C3; 131.0, 
C1; 148.0, C4 or C5; 148.3, C5 or C4. MS (c.i., NH3) m/z 262 (MH, 98%), 260 (MH, 100), 182 (20), 
180 (14).) 
2-Bromo-4, 5-dimethoxyl-1-(2-phthalimidoethyl)benzene (8b) 
Br
N
MeO
MeO
O
O
 
2-(2-Bromo-4,5-dimethoxyphenyl)ethanamine (8f) (3.5 g, 13.2 mmol) was dissolved in 50 mL of dry 
acetonitrile and phthaloyl dichloride (2.14 mL, 14.5 mmol) and diisopropylethylamine (7 mL, 39.6 
mmol) were added. This mixture was stirred at room temperature for 14 h. The acetonitrile was removed 
by rotary evaporation and the remaining material was taken up in dichloromethane and washed with 
alkaline water (pH = 11).  The aqueous wash was extracted with dichloromethane (3 × 15 mL), and the 
organic fractions were combined and dried over sodium sulfate. The solvent was removed by rotary 
evaporation to give a colorless solid. This crude product was dissolved in dichloromethane and loaded 
on top of a silica gel column (60 Å silica) and the purified product was eluted with dichloromethane (Rf 
= 0.2). The solvent was removed by rotary evaporation to give 8b (1.8 g, 34%). 1H NMR (CDCl3, 400 
MHz, 25 °C): δ 7.83 (m, 2H, phthalimide), 7.71 (m, 2H, phthalimide), 7.00 (s, 1H, H6), 6.68 (s, 1H, 
H3), 3.96 (t, J = 7.02 Hz, 2H, CH2), 3.84 (s, 3H, OMe), 3.72 (s, 3H, OMe), 3.08 (t, 2H, J = 7.02 Hz, 
CH2); 13C NMR (CDCl3, 100 MHz, 25 °C) δ 168.17 (CO), 148.35 (C5), 148.30 (C4), 133.97 (C3’/C6’), 
132.04 (C1’/C2’), 129.30 (C2), 123.24 (C4’/C5’), 115.54 (C6), 114.50 (C1), 113.20 (C3), 56.08 (OMe), 
55.95 (OMe), 37.65 (CH2), 34.40 (CH2); HRMS (ESI): calcd. for C18H16O4NBr [M + Na]+ 412.0160, 
414.0140 found 412.0173, 414.0143. (lit.10: 1H NMR (CDCl3, 200 MHz): δ 2.99 (2H, dd, H-β); 3.63 
(3H, S, OCH3); 3.75 (3H, s, OCH3); 3.88 (2H, dd, H-α); 6.65 (1H, s, H-3), 6.91 (1H, s, H-6); 7.64 (2H, 
tt, H-5’, H-6’); 7.75 (2H, dddd, H-4’, H-7’).) 
(4,5-Dimethoxy-2-(2-phthalimido)phenyl)tributyltin (8c) 
SnBu3
N
MeO
MeO
O
O
 
In a glove box under nitrogen, 2-bromo-4,5-dimethoxy-1-(2-phthalimidoethyl)benzene (8b) (1.945 g, 5 
mmol) and Pd(0)(PPh3)4 (289 mg ,0.25 mmol) was dissolved in 15 mL of dry toluene. The solution was 
transferred into a storage tube equipped with a PTFE chemcap seal and hexabutylditin (3.19 g, 5 mmol) 
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was added. The tube was sealed, removed from the glove box, and heated to at 120 °C for 48 h. The 
reaction mixture was allowed to cool to room temperature and diluted with hexane (15 mL) before 
saturated aqueous KF solution (15 mL) was added. The mixture was stirred for 30 min, filtered through 
celite, and the organic layer was separated. The solvent was removed to give the crude product as a 
yellow oil. The crude product was purified by column chromatography (Rf = 0.4, 
hexane/dichloromethane 95/5, basic alumina) to give 0.68 g (22.6%) of (4,5-dimethoxy-2-(2-
phthalimido)phenyl)tributyltin. 1H NMR (C6D6, 400 MHz, 25 °C): δ 7.41 (m, 2H, phthalimide), 7.10 (s, 
1H, H3), 7.01 (s, 1H, H6), 6.84 (m, 2H, phthalimide), 3.93 (t, J= 8.14 Hz, 2H, CH2), 3.56 (s, 3H, OMe), 
3.43 (s, 3H, OMe), 3.12 (t, J = 8.14 Hz, 2H, CH2), 1.73 (m, 6H, βCH2), 1.44 (m, 6H, γCH2), 1.35 (m, 
6H, αCH2), 0.960 (t, J = 7 Hz, 9H, CH3), (coupling to 117Sn and 119Sn observed, J ranged from 8.14 – 
50.48 Hz); 13C NMR (C6D6, 100 MHz, 25 °C) δ 167.64 (CO), 150.70 (C4), 147.40 (C2), 137.95 (C5), 
133.21 (C3’/C6’), 132.39 (C1’/C2’), 132.00 (C1), 122.73 (C4’/C5’), 120.50 (C6), 55.64 (OMe), 55.05 
(OMe), 39.90 (CH2), 37.71 (CH2), 29.54 (γC), 27.66 (βC), 13.76 (δC), 10.66 (αC), (coupling to 117Sn 
and 119Sn observed, J ranged from 1.0 – 322.00 Hz); HRMS (HRCI): calcd. for C30H43O4NSn [M + H]+ 
602.2292, found 602.2281. 
(4,5-Dimethoxy-2-(2-phthalimidoethyl)phenyl)-(4’-methoxyphenyl)iodonium hexafluorophosphate 
(8d)  
IMeO
P
F
F F
F
F
F
OMe
OMe
N
O
O  
In a glove box under nitrogen, 1-(diacetoxyiodo)-4-methoxybenzene (352 mg, 1 mmol) was dissolved in 
1.5 mL of dry acetonitrile. A solution containing p-toluenesulfonic acid monohydrate (190 mg, 1 mmol) 
dissolved in 1.5 mL of dry acetonitrile was added by syringe. Upon completion of the addition, (4,5-
dimethoxy-2-(2-phthalimido)phenyl)tributyltin (9c) (601 mg, 1 mmol) was added and the mixture was 
allowed to stir at room temperature for 2 h outside the glove box. Water (10 mL) was added and the 
mixture was transferred to a separatory funnel and extracted (3 × 5 mL) with hexanes. The reserved 
aqueous layer was treated with 502 mg (3 mmol) of NaPF6. The white precipitate was filtered, dried in 
vacuo, and recrystallized in a mixture of diethyl ether/dichloromethane to give 379 mg (55%) of (4,5-
dimethoxy-2-(2-phthalimidoethyl)phenyl)-(4’-methoxyphenyl)iodonium hexafluorophosphate. 1H NMR 
(CD3CN, 400 MHz, 25 °C): δ 8.00 (d, J = 9.15 Hz, 2H, H2’’/H6’’), 7.81 (m, 4H, phthalimide), 7.61 (s, 
1H, H6), 7.37 (s, 1H, H3), 7.00 (d, J = 9.15 Hz, 2H, H3’’/H5’’), 3.87 (t, J = 7.52 Hz, CH2), 3.85 (s, 3H, 
OMe), 3.81 (s, 3H, OMe), 3.78 (s, 3H, OMe), 3.20 (t, J = 7.52 Hz, CH2); 13C NMR (CD3CN, 100 MHz, 
25 °C) δ 168.21 (CO), 163.08 (C4’’), 153.25 (C4), 149.95 (C5), 136.80 (C2’’/C6’’), 135.06 (C2), 
134.41 (C3’/C6’), 132.01 (C1’/C2’), 123.06 (C4’/C5’), 119.54 (C3), 118.06 (C3’’/C5’’), 113.73 (C6), 
106.01 (C1), 101.80 (C1’’), 56.22 (OMe), 55.85 (OMe), 55.69 (OMe), 38.04 (CH2), 36.67 (CH2); 19F 
NMR (CD3CN, 376 MHz, 25 °C) δ -72.785 (d, 1JP-F = 706.59 Hz, PF6−) ; HRMS (HRFAB): calcd. for 
C25H23O5NPF6I [M – PF6]+ 544.0621, found 544.0615. 
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β-Estradiol (9g)11 
Me
H H
H
HO
OH
 
A solution of estrone (2.60 g, 9.62 mmol) in 130 mL of methanol was treated with concentrated aqueous 
NaOH (1.14 g, 28.5 mmol) and added to a stirred solution of NaBH4 (0.97 g, 25.53 mmol) in 130 mL of 
methanol. H2 evolution ceased after about 45 min, and the mixture was poured into 200 mL of water and 
neutralized with 3 M HCl. The precipitate was filtered, washed with water and recrystallized from hot 
aqueous methanol to give β-estradiol (2.54 g, 97% from two crops). 1H NMR (DMSO-d6, 400 MHz, 25 
°C): δ 8.983 (s, 1H), 7.044 (d, J = 8.4 Hz, 1H), 6.500 (d, J = 8.4 Hz, 1H), 6.428 (s, 1H), 4.496 (d, J = 4.8 
Hz, 1H), 3.52 (m, 1H), 2.697 (m, 2H), 2.229 (m, 1H), 2.065 (m, 1H), 1.94-1.73 (m, 3H), 1.582 (m, 1H), 
1.43-1.05 (m, 7H), 0.665 (s, 3H); 13C NMR (DMSO-d6, 100 MHz, 25 °C): δ 154.89, 137.14, 130.42, 
126.05, 114.91, 112.71, 80.06, 49.52, 43.54, 42.82, 38.70, 36.60, 29.90, 29.17, 26.96, 26.09, 22.79, 
11.28; HRMS (ESI) calcd. for C18H24O2Na [M + Na]+ 295.1674 found 295.1668. 
3,17-Dimethoxy-β-estra-1,3,5(10)-triene (9f)12 
Me
H H
H
MeO
OMe
 
A previously reported procedure12 was improved slightly. β-Estradiol (9g) (2.54 g, 9.32 mmol) was 
dissolved in 125 mL of dry THF under N2 and cooled to 0 °C. NaH (1.07 g, 44.58 mmol) was added, 
and the reaction mixture was stirred for 15 min. CH3I (5.40 mL, 86.48 mmol) was added by syringe, and 
the turbid reaction mixture was stirred overnight and allowed to warm slowly to room temperature. The 
reaction mixture was poured carefully into ice-water. After the effervescence ceased, the organic 
product was extracted into EtOAc (3 x 125 mL), washed with aqueous NaHCO3 (125 mL), and dried 
over anhydrous MgSO4. The solvent was removed in vacuo to afford 3,17-dimethoxy-β-estra-1,3,5(10)-
triene (2.33 g, 83%) as an off-white solid. 1H NMR (CDCl3, 400 MHz, 25 °C): δ 7.218 (d, J = 8.6 Hz, 
1H), 6.722 (dd, J1 = 8.6 Hz, J2 = 2.6 Hz, 1H), 6.640 (d, J = 2.6 Hz, 1H), 3.787 (s, 3H), 3.391 (s, 3H), 
3.327 (t, J = 8.3 Hz, 1H), 2.861 (m, 2H), 2.297 (m, 1H), 2.200 (m, 1H), 2.15-2.00 (m, 2H), 1.94-1.84 (m, 
1H), 1.76-1.64 (m, 1H), 1.58-1.15 (m, 7H), 0.800 (s, 3H); 13C NMR (CDCl3, 100 MHz, 25 °C): δ 
157.61, 138.19, 132.89, 126.55, 113.97, 111.66, 91.01, 58.13, 55.41, 50.49, 44.13, 43.43, 38.81, 38.27, 
30.04, 27.98, 27.44, 26.67, 23.26, 11.76; HRMS (ESI) calcd. for C20H28O2Na [M + Na]+ 323.1987 found 
323.1994. (Lit.12: 1H NMR (CDCl3): δ 7.18 (d, J = 8.63 Hz, 1H), 6.68 (d, J = 8.54 Hz, 1H), 6.60 (s, 1H), 
3.75 (s, 3H), 3.36 (s, 3H), 3.29 (t, J = 16.62 Hz, 1H), 2.84 (m, 2H), 2.25 (m, 1H), 2.15 (t, J = 21.87 Hz, 
1H), 2.02 (m, 2H), 1.84 (m, 1H), 1.66 (m, 1H), 1.52-1.17 (m, 7H), 0.77 (s, 3H); LRMS (CI): m/z (rel 
intensity) 301 (MH+, 100).) 
2-Bromo-3,17-dimethoxy-β-estra-1,3,5(10)-triene (9b)13 
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Me
H H
H
MeO
OMe
Br
 
A solution of N-bromosuccinimide (1.51 g, 8.5 mmol) in CH3CN (30 mL) was added to a CCl4 solution 
(70 mL) of dimethoxy-β-estra-1,3,5(10)-triene (9f) (2.32 g, 7.72 mmol), and the resulting mixture was 
stirred at room temperature protected from light for 2.5 h. The solvent was removed in vacuo to obtain a 
residual mixture of a yellow oil and a white solid. CCl4 was added and the solution was filtered and 
evaporated to give a yellow oil. The oil was triturated in warm methanol to yield a crude solid, which 
was determined by 1H-NMR to be an 80:20 mixture of the 2-bromo and the 4-bromo estradiol dimethyl 
ethers (2.30 g, 78.5%). Recrystallization of the crude product mixture from hot methanol (1st crop) gave 
2-Bromo-3,17-dimethoxy-β-estra-1,3,5(10)-triene (1.40g, 48%) as a white solid in 95% purity, with the 
4-bromo isomer as a trace impurity. The solid was carried forward to the next step without further 
purification. 1H NMR (CDCl3, 400 MHz, 25 °C): δ 7.434 (s, 1H), 6.615 (s, 1H), 3.860 (s, 3H), 3.385 (s, 
3H), 3.319 (t, J = 8.4 Hz, 1H), 2.820 (m, 2H), 2.29-2.01 (m, 4H), 1.93-1.85 (m, 1H), 1.75-1.64 (m, 1H), 
1.58-1.15 (m, 7H), 0.796 (s, 3H); 13C NMR (CDCl3, 100 MHz, 25 °C): δ 153.70, 137.40, 134.47, 
130.44, 112.50, 108.74, 90.89, 58.13, 56.40, 50.38, 43.90, 43.39, 38.53, 38.10, 29.82, 27.96,27.26, 
26.63, 23.23, 11.34; HRMS (FAB) calcd. for C20H27O2Br [M]+ 378.1194, 380.1174 found 378.1149, 
380.1174. 
2-tributylstannyl-3,17-dimethoxy-β-estra-1,3,5(10)-triene (9c)7 
Me
H H
H
MeO
OMe
Bu3Sn
 
A THF solution of the bromosteroid 9b (0.7 g, 1.84 mmol in 20 mL) was cooled to -78 °C under N2. n-
BuLi (2.47 M in hexanes, 0.78 mL, 1.93 mmol) was added dropwise with stirring, and the resulting 
solution was stirred at -78 °C for 30 min. Bu3SnCl (0.52 mL, 1.93 mmol) was then added dropwise at -
78 °C, and the resultant mixture allowed to warm to room temperature over 12 h. Diethyl ether (50 mL) 
was added to the reaction mixture and the organic solvents were was washed with water (3 x 50 mL). 
The organic layer was mixed with KF (0.1 g in 1 mL EtOH) and stirred for a few minutes to remove any 
residual Bu3SnCl. The mixture was washed with water, and the organic layer was dried over anhydrous 
MgSO4. The solvent was removed in vacuo to obtain 2-tributylstannyl-3,17-dimethoxy-β-estra-
1,3,5(10)-triene (10c) as a colorless, viscous oil (0.87 g, 80%). 1H NMR (CD2Cl2, 400 MHz, 25 °C): δ 
7.229 (s, 3JSn-H = 46.4 Hz, 1H), 6.521 (s, 4JSn-H = 17.4 Hz, 1H), 3.705 (s, 3H), 3.330 (s, 3H), 3.292 (t, J = 
8.3 Hz, 1H), 2.92-2.74 (m, 2H), 2.306 (m, 1H), 2.188 (m, 1H), 2.10-1.96 (m, 2H), 1.93-1.82 (m, 1H), 
1.72-1.16 (m, 8H, Halicyclic on steroid overlapping with m centered ~ δ 1.52, 6H, βCH2 and m centered ~ 
δ 1.32, 6H, γCH2), 1.001 (m, 6H, αCH2), 0.878 (t, J = 7.3 Hz, 9H, CH3), 0.763 (s, 3H); 13C NMR 
(CD2Cl2, 100 MHz, 25 °C): δ 162.48, 138.91, 134.41, 133.16, 127.03, 109.82, 91.27, 58.07, 55.56, 
50.79, 44.69, 43.79, 39.42, 38.68, 30.68, 29.76, 28.25, 27.95, 27.86, 27.14, 23.58, 14.06, 11.95, 10.26; 
HRMS (FAB) calcd. for C32H54O2Sn [M]+ 590.3146 found 590.3130.  
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(3,17-dimethoxy-β-estra-1,3,5(10)-trien-2-yl)-(4’-methoxyphenyl)iodonium hexafluorophosphate 
(9d) 
Me
H H
H
MeO
OMe
I
MeO PF
F F
F
F
F
 
In a glove box under nitrogen, CH3CN solutions of 1-(diacetoxyiodo)-4-methoxybenzene (65 mg, 0.19 
mmol in 1 mL) and tosylic acid monohydrate (35 mg, 0.19 mmol in 1 mL) were mixed together to 
generate a Koser’s type reagent. The yellow reagent mixture was added to a THF solution of 2-
tributylstannyl-3,17-dimethoxy-β-estra-1,3,5(10)-triene (9c) (112 mg, 0.19 mmol in 1 mL), and the 
resultant pale yellow reaction mixture was stirred overnight protected from light. The reaction mixture 
was brought out of the box, and the solvent was removed in vacuo to obtain a white solid residue. The 
solid was washed with hexanes, redissolved in CH3CN and extracted with hexanes to remove the 
alkyltin byproducts. Solvent was removed from the CH3CN layer to obtain a colorless oil. The oil was 
dissolved in about 5 mL of CH3CN and water (25 mL) and NaPF6 (96 mg, 0.57 mmol) were added; the 
solution turned into a milky suspension. The mixture was extracted with CH2Cl2 and the organic 
solvents were removed in vacuo to obtain a colorless oil. The oil was triturated twice with hexanes to 
afford a pale brown solid. The solid was separated and dissolved in CH3CN and filtered. The solvent 
was removed in vacuo and the sticky solid was triturated again with hexanes to give (3,17-dimethoxy-β-
estra-1,3,5(10)-trien-2-yl)-(4’-methoxyphenyl)iodonium hexafluorophosphate (9d) as a pale brown solid 
(84 mg, 65%).  The solid was collected by filtration and dried under dynamic high vacuum in a P2O5 
drying pistol (3 d) before fluorination was attempted. 1H NMR (CD3CN, 400 MHz, 25 °C): δ 7.953 (d, J 
= 8.8 Hz, 2H), 7.826 (s, 1H), 7.018 (d, J = 8.8 Hz, 2H), 6.933 (s, 1H), 3.895 (s, 3H), 3.828 (s, 3H), 3.36-
3.23 (s overlapping with t, 4H), 2.918 (m, 2H), 2.28-2.12 (m, 2H), 2.12-1.81 (m overlapping with 
solvent, 3H), 1.672 (m, 1H), 1.52-1.14 (m, 7H), 0.743 (s, 3H); 13C NMR (CD3CN, 100 MHz, 25 °C): δ 
164.52, 155.71, 147.38, 139.13, 138.45, 134.81, 119.23, 114.65, 101.98, 101.67, 91.59, 58.27, 58.23, 
57.03, 51.15, 44.94, 44.29, 39.15, 38.81, 30.92, 28.69, 27.60, 27.44, 24.01, 12.35; 19F NMR (CD3CN, 
376 MHz, 25 °C): δ -72.876 (d, 1JP-F = 706.9 Hz, PF6-); 31P NMR (CD3CN, 162 MHz, 25 °C): δ -
144.525 (septet, 1JP-F = 706.9 Hz, PF6-); HRMS ( FAB) calcd for C27H34IO3 [M – PF6]+ 533.1553 found 
533.1561. 
General procedure for fluorination of diaryliodonium salts in acetonitrile: In a nitrogen atmosphere 
glove box, 0.05 mmol of the appropriate aryl(4-methoxyphenyl)-iodonium hexafluorophosphate and 
0.05 mmol of TMAF were dissolved in 0.6 mL of dry acetonitrile. The solution was transferred into a J-
Young NMR tube, sealed, and taken out of the glove box. The tube was wrapped in aluminum foil and 
placed in a 140 °C oil bath. After 15 minutes, no remaining starting material was observable by 1H 
NMR spectroscopy. Yields of the reactions are recorded in manuscript table 1.   
 
General procedure for fluorination of diaryliodonium salts in benzene: In a nitrogen atmosphere 
glove box, 0.05 mmol of the appropriate aryl(4-methoxyphenyl)-fluoro-λ3-iodane and 0.05 mmol of 
TMAOTf were dissolved in 0.6 mL of dry d6-benzene. The solution was transferred into a J-Young 
NMR tube, sealed, and taken out of the glove box. The tube was wrapped in aluminum foil and placed in 
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a 140 °C oil bath. After 15 minutes, no remaining starting material was observable by 1H NMR 
spectroscopy. Yields of the reactions are recorded in manuscript table 1.   
 
General procedure for fluorination of diaryliodonium salts in benzene, toluene and acetonitrile 
under salt-free conditions: In a nitrogen atmosphere glove box, 0.05 mmol of an appropriate aryl(4-
methoxyphenyl)-iodonium hexafluorophosphate was dissolved in 0.3 mL of dry acetonitrile. A solution 
of 0.05 mmol of TMAF in 0.3 mL of dry acetonitrile was added slowly. The mixture was transferred 
into a J-Young NMR tube, sealed, and taken out of the glove box. The solvent was evaporated and the 
tube was taken back into the glove box. Dry benzene-d6 or toluene-d8 (0.6 mL) was added and the 
solution was passed through a 0.2 mm membrane filter and transferred into a J-Young NMR tube, 
sealed, and taken out of the glove box. (For decomposition in acetonitrile, regular benzene was used to 
dissolve the iodonium fluoride, removed by vacuum and d3-acetonitrile was added). The tube was 
wrapped in aluminum foil and placed in a 140 °C oil bath. After 15 minutes, no remaining starting 
material was observable by 1H NMR spectroscopy. Yields of the reactions are recorded in manuscript 
tables 2 and S1.   
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Table S1. Yields of fluorinated arenes obtained from decomposition of salts 1-7 after removal of 
TMAPF6. in d8-toluene. 
C7D8 Cmpd. 
(ArF +  4FA)a 
1 83 
2 (76 + 12) 
3 (53 + 21) 
4 (72 + 17) 
5 (55 + 18) 
6 (89 + 10) 
7 (87 + 0) 
a The numbers inside the parentheses indicate the percentage yields of the desired fluorinated arenes followed by the amount 
of 4-fluoroanisole (4FA) produced during the reaction.  All solutions were heated at 140 ºC for 15 minutes in sealed NMR 
tubes. 
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